Sign in
PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAïVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
Abstract   Peer reviewed

PD26-03 SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR BCG-NAïVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

Ian M. McElree, Ryan L. Steinberg, Alexander C. Martin, Jordan Richards, Sarah L. Mott, Paul T. Gellhaus, Kenneth G. Nepple, Michael A. O'Donnell and Vignesh T. Packiam
The Journal of urology, Vol.207(Supplement 5)
05/2022
DOI: 10.1097/JU.0000000000002574.03

View Online

Details

Metrics

11 Record Views